Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver disease
Symptom C0085584|encephalopathy
Sentences 31
PubMedID- 24367225 Information about demography, hav infections and vaccination status, diagnostic data for fhf using the pediatric acute liver failure criteria, clinical laboratory results, encephalopathy, the severity of liver disease using the pediatric end stage liver disease score, assessment of patients on the lt waiting list using king’s college criteria for lt, treatment given for fhf (pre- and post-transplant), and clinical outcome were collected using a case report form.
PubMedID- 25908985 These include hepatic encephalopathy in patients with advanced liver disease, vascular bypass of the liver, valproic acid or cyclophosphamide poisoning, herpes simplex infection, and gastrointestinal bacterial overgrowth.
PubMedID- 20412038 Hepatic encephalopathy, a common complication of chronic liver disease, contributes to this economic burden.
PubMedID- 21384402 Additional studies are warranted to evaluate the effects of ast-120 on hepatic encephalopathy in patients with advanced liver disease.
PubMedID- PMC2934573 Alf was defined as an inr >1.5 and encephalopathy in the absence of chronic liver disease.
PubMedID- 25755535 Hepatic encephalopathy in the setting of advanced chronic liver disease, occurs following a precipitating factor and generally responds to correction of the precipitating factor and anticoma measures.
PubMedID- 21959704 Minimal encephalopathy was originally associated with chronic liver disease but is increasingly associated with most other chronic diseases and particularly with diabetes and also chronic disorders in other organs: kidneys, lungs, thyroid and with obesity.
PubMedID- 23978689 Alf is characterized by coagulopathy and hepatic encephalopathy (he) in a patient without pre-existing liver disease.
PubMedID- 21705899 Objective: hyperammonemia is a major contributing factor to the encephalopathy associated with liver disease.
PubMedID- 25586470 Objectives: rifaximin is approved for the reduction of hepatic encephalopathy (he) recurrence in patients with chronic liver disease (cld); however, few studies have evaluated the benefit of adding rifaximin to lactulose for treatment of acute he.
PubMedID- 26029995 Objectives: acute liver failure is a life-threatening condition with sudden onset liver injury, decreased liver functions, hepatic encephalopathy, and coagulopathy in patients without preexisting liver disease.
PubMedID- 25793766 Both these factors, in addition to minimal hepatic encephalopathy due to liver disease, may favour cognitive dysfunction, falls and alterations in white matter integrity .
PubMedID- 24367215 The definition of hepatic encephalopathy is difficult in patients with alcoholic liver disease who have initial neurologic manifestations as part of diffuse central and peripheral neuropathy.
PubMedID- 25374704 Metronidazole-induced encephalopathy in a patient with end-stage liver disease.
PubMedID- 20880508 Many theories have been advanced to explain the encephalopathy associated with chronic liver disease and with the less common acute form.
PubMedID- 26426612 Hepatitis b virus (hbv) infection is a global health problem, with a seroprevalence varying from 1.7% (latin america) to 11.3% (east asia and pacific).1 hbv infection is associated with an increased risk of cirrhosis, hepatic decompensation, and hepatocellular carcinoma.2 hepatic decompensation may be gradual or acute, which is termed acute-on-chronic liver failure (aclf).3 patients with chronic hepatitis b (chb) may experience a severe acute exacerbation of the disease that progresses into liver failure, which is defined as acute-on-chronic hepatitis b liver failure (achblf), manifesting as jaundice and coagulopathy (international normalized ratio inr > 1.5) complicated within 4 weeks by ascites and/or encephalopathy in a patient with chronic liver disease.3,4 liver transplantation is the only curative therapeutic option for aclf, with a 5-year survival rate of 85%.
PubMedID- 24829827 We conclude that acute maternal hepatic encephalopathy and hyperammonemia due to chronic liver disease do not portend adverse neonatal outcomes, notably encephalopathy.
PubMedID- 21741091 Rifaximin received new labeling for reduction in the risk of the recurrence of overt hepatic encephalopathy (he) in patients with advanced liver disease in march of 2010.
PubMedID- 24498036 These data have been routinely collected since january 2001 and include non-aids malignancies, pancreatitis, severe liver disease with hepatic encephalopathy (grade 3 or 4), cardio- and cerebrovascular events (i.e.
PubMedID- 22867045 All opioid drugs can precipitate or aggravate hepatic encephalopathy in patients with severe liver disease, thus requiring cautious use and careful monitoring.
PubMedID- 23936100 This characteristic profile is typical of hepatic encephalopathy associated with chronic liver disease and portosystemic shunting , , , , , .
PubMedID- 22228885 The aim of this study was to evaluate scientific evidence for the effectiveness and safety of lola infusions for treatment of clinical hepatic encephalopathy in patients with chronic liver disease.
PubMedID- 25068951 Acute liver failure (alf) is an uncommon clinical syndrome that often has a course associated with rapidly progressive multiorgan failure and devastating complications like coagulopathy and encephalopathy in patients without previous liver disease.
PubMedID- 20728575 No state specifically mentioned hepatic encephalopathy or patients with advanced liver disease.
PubMedID- 25733099 The primary outcome was drug-induced alf (defined as coagulopathy and hepatic encephalopathy without underlying chronic liver disease), determined by hepatologists who reviewed medical records of all kpnc members with inpatient diagnostic and laboratory criteria suggesting potential alf.
PubMedID- 26098218 In the intestine, bacterial urease converts host-derived urea to ammonia and carbon dioxide, contributing to hyperammonemia-associated neurotoxicity and encephalopathy in patients with liver disease.
PubMedID- 23049548 Minimal encephalopathy is a condition of chronic liver disease with no clinical symptoms of brain dysfunction.
PubMedID- 22447259 Acute liver failure (alf) (sometimes referred to as fulminant hepatic failure) is a clinical syndrome from a variety of causes resulting from rapid loss in hepatocyte function, typically associated with coagulopathy and encephalopathy in a patient without preexisting liver disease or cirrhosis.
PubMedID- 25867912 Comparison of once a day rifaximin to twice a day dosage in the prevention of recurrence of hepatic encephalopathy in patients with chronic liver disease.
PubMedID- 24133449 Alf results from the acute and rapid loss of hepatocyte function, and is associated with coagulopathy international normalized ratio (inr) >1.5 and hepatic encephalopathy (he) in a patient without pre-existing liver disease.
PubMedID- 24643925 Hepatic encephalopathy in the course of alcoholic liver disease--treatment options in the intensive care unit.

Page: 1